Severe acute respiratory syndrome caused by the novel coronavirus (SARS-CoV-2) was first
reported in China in December 2019 which was later declared to be a public health …

Abstract The coronavirus disease 2019 (COVID-19) pandemic has had a profound and often
devastating impact on global healthcare systems. Healthcare systems have had to …

Since the beginning of 2020, the ongoing coronavirus disease (COVID-19) pandemic has
resulted in the deaths of more than 250,000 patients in the European Union/European …

Abstract The coronavirus disease 2019 (COVID-19) caused by the severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) has spread worldwide. Bacterial co-infections are …

Since first identified in late 2019, the acute respiratory syndrome coronavirus (SARS-CoV2)
and the resulting coronavirus disease (COVID-19) pandemic has overwhelmed healthcare …

During the COVID-19 pandemic, the implementation of antimicrobial stewardship strategies
has been recommended. This study aimed to assess the impact of the COVID-19 pandemic …

This study aims to prepare natural biomass-based nonionic antimicrobial polymers with
excellent biocompatibility, nonleachability, antimicrobial activity, and polymer miscibility …

The COVID-19 pandemic is expected to worsen the global problem of antimicrobial
resistance (AMR). There is a heightened interest in understanding this effect and to develop …

Background: The COVID-19 pandemic poses novel challenges in antimicrobial consumption
metrics and stewardship strategies. COVID-19 patients became the major cause of hospital …

Background: COVID-19 has a widely variable clinical syndrome that is difficult to distinguish
from bacterial sepsis, leading to high rates of antibiotic use. Early studies indicate low rates …